VC  Illinois Ventures

http://www.illinoisventures.com





     Office Locations:

200 S. Wacker Floor 20, Suite 2000
Chicago, IL 60606
Phone: 312-996-9853

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early
  • Seed


 

Industries:

  • Defense & Homeland Security
  • Energy & Clean Tech
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Illinois Ventures is a seed and early-stage technology investment firm focused on research-derived companies in information technologies, physical sciences and life sciences, with a particular emphasis on those deriving from research conducted at the University of Illinois and other regional research institutions and federal laboratories. Current investments reflect targeted practice areas in energy, device physics, advanced materials, biotechnology, medical devices and instrumentation, homeland security, and software. Illinois Ventures currently invests up to $200,000 in seed-stage opportunities developed at the University of Illinois, often as the first or one of the first outside investors in a promising new technology-based startup. During the course of the past ten years Illinois Ventures has led or collaborated on the initial funding of over 87 new ventures spanning a broad spectrum of scientific and technological innovation across multiple domains.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Nancy Harvey Senior Director and Principal
    Nancy Sullivan CEO, Managing Director, and Managing Principal
    Thomas E. Parkinso Senior Director, Principal, and Venture Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      06/17/2024


      Elion Therapeutics


      NY


      $81,000,000


      Series B


     

    Portfolio companies include:


      Agrible


      Apervita
        web link


      Cast 21


      Chromatin
        web link


      Deep Walk


      Elion Therapeutics
        web link


      Graykea


      Iris Mobile
        web link


      Natrion
        web link


      Network Perception
        web link


      Petrichor


      Phi Optics
        web link


      Psyonic


      Reconstruct


      Revenew
        web link


      Revivio Therapeutics


      Sfunga Therapeutics


      Xaptum


     

    Recent News: